[1] |
López⁃Romero E, Reyes⁃Montes MR, Pérez⁃Torres A, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem[J]. Future Microbiol, 2011, 6(1): 85⁃102. DOI: 10.2217/fmb.10.157.
|
[2] |
Guzman⁃Beltran S, Perez⁃Torres A, Coronel⁃Cruz C, et al. Phagocytic receptors on macrophages distinguish between different Sporothrix schenckii morphotypes[J]. Microbes Infect, 2012, 14(12): 1093⁃1101. DOI: 10.1016/j.micinf.2012.06.001.
|
[3] |
Lopes⁃Bezerra LM, Schubach A, Costa RO. Sporothrix schenckii and sporotrichosis[J]. An Acad Bras Cienc, 2006, 78(2): 293⁃308. DOI: /S0001⁃37652006000200009.
|
[4] |
Rivera A, Siracusa MC, Yap GS, et al. Innate cell communication kick⁃starts pathogen⁃specific immunity[J]. Nat Immunol, 2016, 17(4): 356⁃363. DOI: 10.1038/ni.3375.
|
[5] |
Sassá MF, Ferreira LS, Ribeiro LC, et al. Immune response against Sporothrix schenckii in TLR⁃4⁃deficient mice[J]. Mycopathologia, 2012, 174(1): 21⁃30. DOI: 10.1007/s11046⁃012⁃9523⁃1.
|
[6] |
Romo⁃Lozano Y, Hernández⁃Hernández F, Salinas E. Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL⁃6 and TNF⁃α in rat mast cells, but no degranulation[J]. Med Mycol, 2014, 52(8): 862⁃868. DOI: 10.1093/mmy/myu055.
|
[7] |
Franco DL, Nascimento RC, Ferreira KS, et al. Antibodies against Sporothrix schenckii enhance TNF⁃α production and killing by macrophages[J]. Scand J Immunol, 2012, 75(2): 142⁃146. DOI: 10.1111/j.1365⁃3083.2011.02636.x.
|
[8] |
Ferreira LS, Gonçalves AC, Portuondo DL, et al. Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection[J]. Immunobiology, 2015, 220(8): 985⁃992. DOI: 10.1016/j.imbio.2015.02.009.
|
[9] |
Negrini TC, Ferreira LS, Alegranci P, et al. Role of TLR⁃2 and fungal surface antigens on innate immune response against Sporothrix schenckii[J]. Immunol Invest, 2013, 42(1): 36⁃48. DOI: 10.3109/08820139.2012.719982.
|
[10] |
de C Negrini T, Ferreira LS, Arthur RA, et al. Influence of TLR⁃2 in the immune response in the infection induced by fungus Sporothrix schenckii[J]. Immunol Invest, 2014, 43(4): 370⁃390. DOI: 10.3109/08820139.2013.879174.
|
[11] |
Verdan FF, Faleiros JC, Ferreira LS, et al. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro[J]. Immunobiology, 2012, 217(8): 788⁃794. DOI: 10.1016/j.imbio.2012.04.006.
|
[12] |
Hunter CA, Jones SA. IL⁃6 as a keystone cytokine in health and disease[J]. Nat Immunol, 2015, 16(5): 448⁃457. DOI: 10.1038/ni.3153.
|
[13] |
Jones SA. Directing transition from innate to acquired immunity: defining a role for IL⁃6[J]. J Immunol, 2005, 175(6): 3463⁃3468.
|
[14] |
Tukulula M, Hayeshi R, Fonteh P, et al. Curdlan⁃conjugated PLGA nanoparticles possess macrophage stimulant activity and drug delivery capabilities[J]. Pharmaceutical Research, 2015, 32(8): 2713⁃2726. DOI: 10.1007/s11095⁃015⁃1655⁃9.
|
[15] |
Li M, Liu ZH, Chen Q, et al. Insoluble beta⁃glucan from the cell wall of Candida albicans induces immune responses of human THP⁃1 monocytes through Dectin⁃1[J]. Chin Med J (Engl), 2009, 122(5): 496⁃501.
|
[16] |
Hontelez S, Sanecka A, Netea MG, et al. Molecular view on PRR cross⁃talk in antifungal immunity[J]. Cell Microbiol, 2012, 14(4): 467⁃474. DOI: 10.1111/j.1462⁃5822.2012.01748.x.
|
[17] |
段志敏, 杜蕾蕾, 曾荣, 等. 白念珠菌对人急性单核细胞白血病细胞系产生肿瘤坏死因子α、活化信号分子p38MAPK的影响[J]. 中华皮肤科杂志, 2015, 48(8): 535⁃538. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.08.004.
|
[18] |
Bhattacharyya S, Ratajczak CK, Vogt SK, et al. TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll⁃like receptor⁃stimulated macrophages[J]. Blood, 2010, 115(10): 1921⁃1931. DOI: 10.1182/blood⁃2009⁃06⁃224782.
|